TYP 0.00% 1.8¢ tryptamine therapeutics limited

Ann: Independent Plexaris and Cevaris testing, page-4

  1. sle
    10,811 Posts.
    lightbulb Created with Sketch. 349
    Well certainly the newsflow for 2020 has started with a bang!! I'd be interested to see whom we may end up partnering with before year's end and at what tantalizing price???

    Exopharm is now a clinical stage company and the first company in the world to test
    a proprietary exosome product in human clinical trials for regenerative medicine
    • 2020 set to be a year of inflexion points with newsflow, partnering activity and
    clinical trials
    • Seeking to build significant shareholder value
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.